MMJ Trademark

Trademark Overview


On Friday, May 29, 2015, a trademark application was filed for MMJ with the United States Patent and Trademark Office. The USPTO has given the MMJ trademark a serial number of 86646133. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, October 9, 2018. This trademark is owned by MMJ Bioscience Inc.. The MMJ trademark is filed in the Pharmaceutical Products category with the following description:

cannabidiol (CBD) derived from industrial hemp for use in the manufacture of pharmaceuticals; soluble films for use in the manufacture of delivery agents for pharmaceuticals and vitamins; consumer products, namely, body care, skin care, hair care, cosmetics, and personal care products based on CBD derived from industrial hemp, namely, creams, oils, emollients, ointments, rubs, lotions, salves, shampoos, conditioners, hair treatments, scrubs, tonners, masks, drops, oils body wash, butters, exfoliants, moisturizers, and gels; Pharmaceuticals, pharmaceutical preparations, nutraceuticals, and medicines for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, p...
mmj

General Information


Serial Number86646133
Word MarkMMJ
Filing DateFriday, May 29, 2015
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, October 9, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicescannabidiol (CBD) derived from industrial hemp for use in the manufacture of pharmaceuticals; soluble films for use in the manufacture of delivery agents for pharmaceuticals and vitamins; consumer products, namely, body care, skin care, hair care, cosmetics, and personal care products based on CBD derived from industrial hemp, namely, creams, oils, emollients, ointments, rubs, lotions, salves, shampoos, conditioners, hair treatments, scrubs, tonners, masks, drops, oils body wash, butters, exfoliants, moisturizers, and gels; Pharmaceuticals, pharmaceutical preparations, nutraceuticals, and medicines for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; pharmaceuticals, pharmaceutical preparations, nutraceuticals, and medicines containing CBD derived from industrial hemp for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; prescription synthetic narcotics for medical use; nutritional and dietary supplements; nutritional and dietary supplements for general health and wellbeing; magnetically encoded cards, namely, membership and identification cards; magnetically encoded cards for use in connection with customer loyalty, rewards, bonus points, and discount programs; magnetically encoded identification cards for use in connection with customer loyalty, rewards, bonus points, and discount programs; consumer products, namely, edible oils; consumer products, namely, non-alcoholic beverages, namely, soft drinks, fruit drinks, vegetable drinks, and juices; consumer products, namely, smokeless vaporizer pipes and pens; online retail store wholesale services featuring CBD based pharmaceutical and body care products derived from industrial hemp; mail order buying clubs in the field of pharmaceutical products; membership services, namely, the operation and maintenance of an association promoting the interests of retail and wholesale stores in the field of medical marihuana; retail and wholesale store services featuring CBD based pharmaceutical products derived from industrial hemp; retail and wholesale store services featuring pharmaceuticals containing CBDs; promoting the goods and services of others by issuance of rewards cards related to the purchase of CBD based products; retail and wholesale store reward programs to promote the sale of pharmaceuticals containing CBDs; providing a customer loyalty program which promotes the goods and services of others by offering rewards, bonus points or discount offers; providing a website featuring information regarding political and business information regarding the cannabis industry; providing a website and online computer database featuring information regarding health; assembly of pharmaceuticals for others; customized production of pharmaceuticals, pharmaceutical products, nutraceuticals and CBD based products derived from industrial hemp; extraction of CBD derived from industrial hemp; scientific research services in the area of CBD based products derived from industrial hemp; product development services for products containing CBD based products derived from industrial hemp; research and development of products containing CBDs for others for clinical studies; operation of a web site that provides online social networking; Providing a website featuring legal information regarding cannabis and CBDs based products derived from industrial hemp

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 5, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMMJ PHYTOTECH LIMITED
Party Type12 - New Owner Before Publication
Legal Entity Type11 - Company
AddressNEDLANDS, WA 6009
AU

Party NameUNITED GREENERIES HOLDINGS LTD.
Party Type11 - New Owner Before Publication
Legal Entity Type13 - Limited Partnership
AddressVANCOUVER V6C2T5
CA

Party NameMMJ Bioscience Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver V6C2T5
CA

Trademark Events


Event DateEvent Description
Tuesday, October 9, 2018ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, October 9, 2018ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, March 13, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 13, 2018NON-FINAL ACTION E-MAILED
Tuesday, March 13, 2018NON-FINAL ACTION WRITTEN
Wednesday, February 21, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, February 20, 2018LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, August 9, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, August 9, 2017LETTER OF SUSPENSION E-MAILED
Wednesday, August 9, 2017SUSPENSION LETTER WRITTEN
Wednesday, July 5, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 5, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 27, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, February 8, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, January 12, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 12, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, January 7, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Saturday, January 7, 2017INQUIRY TO SUSPENSION E-MAILED
Saturday, January 7, 2017SUSPENSION INQUIRY WRITTEN
Friday, January 6, 2017LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, June 17, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, June 17, 2016LETTER OF SUSPENSION E-MAILED
Friday, June 17, 2016SUSPENSION LETTER WRITTEN
Tuesday, May 17, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 17, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 12, 2016ASSIGNED TO LIE
Friday, April 29, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 29, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 2, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 2, 2015NON-FINAL ACTION E-MAILED
Monday, November 2, 2015NON-FINAL ACTION WRITTEN
Tuesday, October 20, 2015ASSIGNED TO EXAMINER
Tuesday, June 16, 2015ASSIGNED TO EXAMINER
Monday, June 15, 2015ASSIGNED TO EXAMINER
Friday, June 5, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM